NCT05025774 Fitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant BPD Through Exercise Status RECRUITING Phase N/A
NCT05014165 Backtracking Leukemia-Typical Somatic Mutations in Cord Blood Status RECRUITING Phase N/A
NCT04975555 Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector Cell Associated Neurotoxicity (ICANS) Related to CAR-T Cell Therapy Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04969601 Anti-Covid-19 Vaccine in Children With Acute Leukemia and Their Siblings Status COMPLETED Phase PHASE1/PHASE2
NCT04956666 A Roll-over Study to Provide Continued Treatment With Lyophilized Pegaspargase (S95014) in Pediatric Patients With Acute Lymphoblastic Leukemia (ALL) Status COMPLETED Phase PHASE2
NCT04954326 A Study Comparing the Blood Levels of Both Pegaspargase (S95014) Formulations (Liquid vs Lyophilized) in the Treatment of Paediatric Patients With Acute Lymphoblastic Leukemia (ALL) Status COMPLETED Phase PHASE2
NCT04943952 JZP458 - Recombinant Erwinia Asparaginase for Treatment of ALL / LBL Patients With Hypersensitivity to E. Coli-derived Asparaginase Status APPROVED_FOR_MARKETING Phase N/A
NCT04928599 Financial Distress During Treatment for Pediatric Acute Lymphoblastic Leukemia in the United States Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04904588 HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04888468 Phase I Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolescents Status COMPLETED Phase PHASE1
NCT04872478 Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL Status RECRUITING Phase PHASE1
NCT04845035 Pediatric-Inspired Chemotherapy Plus Tyrosine Kinase Inhibitor in Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Status WITHDRAWN Phase PHASE2
NCT04843150 Pharmacokinetics and Immunogenicity of the First Doses of PEG-Asparaginase -An ALLTogether Pilot Study Status COMPLETED Phase N/A
NCT04825548 Post-thrombotic Syndrome After Deep Venous Thrombosis (DVT) in Patients Treated According to the NOPHO ALL2008 Protocol Status COMPLETED Phase N/A
NCT04814004 Clinical Study of CAR-iNKT Cells in the Treatment of Relapsed/Refractory/High-risk B-cell Tumors Status UNKNOWN Phase PHASE1
NCT04796688 Universal Chimeric Antigen Receptor-modified AT19 Cells for CD19+ Relapsed/Refractory Hematological Malignancies Status UNKNOWN Phase PHASE1
NCT04787263 CD19-CAR_Lenti T Cells in Pediatric Patients Affected by Relapsed/Refractory CD19+ ALL and DLBCL or PML Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2